

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of chemokine biosynthetic process (GO:0045080) | 6.32873349 |
| 2 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.92221193 |
| 3 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.92221193 |
| 4 | modulation by symbiont of host immune response (GO:0052553) | 5.92221193 |
| 5 | positive regulation by symbiont of host defense response (GO:0052509) | 5.92221193 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 5.92221193 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.92221193 |
| 8 | response to peptidoglycan (GO:0032494) | 5.84878709 |
| 9 | positive regulation of heat generation (GO:0031652) | 5.20516744 |
| 10 | leukocyte aggregation (GO:0070486) | 5.16051240 |
| 11 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 5.14472543 |
| 12 | regulation of fever generation (GO:0031620) | 5.08390384 |
| 13 | negative regulation of cell killing (GO:0031342) | 5.03045844 |
| 14 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.03045844 |
| 15 | regulation of chemokine biosynthetic process (GO:0045073) | 4.89340957 |
| 16 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.75214895 |
| 17 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.67494526 |
| 18 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.66761802 |
| 19 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.65968009 |
| 20 | response to muramyl dipeptide (GO:0032495) | 4.54842436 |
| 21 | neutrophil activation involved in immune response (GO:0002283) | 4.31719458 |
| 22 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.30038272 |
| 23 | germinal center formation (GO:0002467) | 4.16607387 |
| 24 | macrophage activation involved in immune response (GO:0002281) | 4.15532274 |
| 25 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.12839054 |
| 26 | regulation of vitamin metabolic process (GO:0030656) | 4.11728251 |
| 27 | regulation of heat generation (GO:0031650) | 4.10142443 |
| 28 | negative regulation of interleukin-12 production (GO:0032695) | 4.07446724 |
| 29 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.04163194 |
| 30 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 4.03912900 |
| 31 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 4.02877667 |
| 32 | cellular extravasation (GO:0045123) | 4.02655661 |
| 33 | type I interferon signaling pathway (GO:0060337) | 3.92852774 |
| 34 | cellular response to type I interferon (GO:0071357) | 3.92852774 |
| 35 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.91386751 |
| 36 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.90761617 |
| 37 | response to type I interferon (GO:0034340) | 3.89088407 |
| 38 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.88716521 |
| 39 | response to host immune response (GO:0052572) | 3.88716521 |
| 40 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.87782692 |
| 41 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.81257848 |
| 42 | activation of MAPKKK activity (GO:0000185) | 3.79958683 |
| 43 | regulation of interferon-alpha production (GO:0032647) | 3.78915867 |
| 44 | positive regulation of interferon-alpha production (GO:0032727) | 3.78491251 |
| 45 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.75890103 |
| 46 | low-density lipoprotein particle clearance (GO:0034383) | 3.75543174 |
| 47 | respiratory burst (GO:0045730) | 3.68969446 |
| 48 | microglial cell activation (GO:0001774) | 3.67947742 |
| 49 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.66485058 |
| 50 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.65487985 |
| 51 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.59211884 |
| 52 | regulation of gamma-delta T cell activation (GO:0046643) | 3.59107653 |
| 53 | response to host (GO:0075136) | 3.58935445 |
| 54 | response to host defenses (GO:0052200) | 3.58935445 |
| 55 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.58935445 |
| 56 | defense response to protozoan (GO:0042832) | 3.52057675 |
| 57 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.52000399 |
| 58 | granulocyte activation (GO:0036230) | 3.49364635 |
| 59 | T-helper 1 type immune response (GO:0042088) | 3.48406745 |
| 60 | immunoglobulin mediated immune response (GO:0016064) | 3.44041936 |
| 61 | neutrophil mediated immunity (GO:0002446) | 3.42340275 |
| 62 | superoxide anion generation (GO:0042554) | 3.39597774 |
| 63 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.37611581 |
| 64 | regulation of mast cell degranulation (GO:0043304) | 3.36413499 |
| 65 | detection of molecule of bacterial origin (GO:0032490) | 3.36128643 |
| 66 | positive regulation of chemokine production (GO:0032722) | 3.35649688 |
| 67 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.34855787 |
| 68 | reactive oxygen species biosynthetic process (GO:1903409) | 3.34191297 |
| 69 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.31957849 |
| 70 | positive regulation of mast cell degranulation (GO:0043306) | 3.31957849 |
| 71 | regulation of chronic inflammatory response (GO:0002676) | 3.31611234 |
| 72 | regulation of podosome assembly (GO:0071801) | 3.31544346 |
| 73 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.31539802 |
| 74 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.29584839 |
| 75 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.28632708 |
| 76 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.28038927 |
| 77 | cytokine secretion (GO:0050663) | 3.27834434 |
| 78 | negative regulation of T cell mediated immunity (GO:0002710) | 3.26577178 |
| 79 | detection of other organism (GO:0098543) | 3.25171851 |
| 80 | response to protozoan (GO:0001562) | 3.24830091 |
| 81 | positive regulation of type 2 immune response (GO:0002830) | 3.23538713 |
| 82 | macrophage activation (GO:0042116) | 3.23441304 |
| 83 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.23281341 |
| 84 | positive regulation of acute inflammatory response (GO:0002675) | 3.18072544 |
| 85 | positive regulation of antigen processing and presentation (GO:0002579) | 3.16720015 |
| 86 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.16599061 |
| 87 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.15756365 |
| 88 | neutrophil activation (GO:0042119) | 3.15141761 |
| 89 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.14695720 |
| 90 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.14695720 |
| 91 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.14350827 |
| 92 | myeloid leukocyte mediated immunity (GO:0002444) | 3.12275210 |
| 93 | negative regulation of lipid storage (GO:0010888) | 3.11339177 |
| 94 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.10599649 |
| 95 | chronic inflammatory response (GO:0002544) | 3.09108280 |
| 96 | detection of bacterium (GO:0016045) | 3.08819867 |
| 97 | negative regulation of interleukin-6 production (GO:0032715) | 3.08656422 |
| 98 | response to interleukin-15 (GO:0070672) | 3.08177412 |
| 99 | regulation of NF-kappaB import into nucleus (GO:0042345) | 3.07720516 |
| 100 | regulation of histone phosphorylation (GO:0033127) | 3.06604162 |
| 101 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.05893166 |
| 102 | negative regulation of type 2 immune response (GO:0002829) | 3.05371541 |
| 103 | regulation of type 2 immune response (GO:0002828) | 3.04253758 |
| 104 | positive regulation of p38MAPK cascade (GO:1900745) | 3.03896186 |
| 105 | detection of external biotic stimulus (GO:0098581) | 3.03562058 |
| 106 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.03116827 |
| 107 | positive regulation of interleukin-6 production (GO:0032755) | 3.02666569 |
| 108 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.00537002 |
| 109 | regulation of tolerance induction (GO:0002643) | 3.00300656 |
| 110 | positive regulation of mast cell activation (GO:0033005) | 2.98812982 |
| 111 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.98261347 |
| 112 | myeloid cell activation involved in immune response (GO:0002275) | 2.97973111 |
| 113 | B cell mediated immunity (GO:0019724) | 2.97812509 |
| 114 | neutrophil chemotaxis (GO:0030593) | 2.97553261 |
| 115 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.97039723 |
| 116 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.95960976 |
| 117 | detection of biotic stimulus (GO:0009595) | 2.95269862 |
| 118 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.95022460 |
| 119 | regulation of T cell tolerance induction (GO:0002664) | 2.94465215 |
| 120 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.94341277 |
| 121 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.94066790 |
| 122 | positive regulation of transcription factor import into nucleus (GO:0042993) | 2.93663157 |
| 123 | regulation of mononuclear cell migration (GO:0071675) | 2.92603429 |
| 124 | neutrophil migration (GO:1990266) | 2.88902768 |
| 125 | eosinophil migration (GO:0072677) | 2.88353111 |
| 126 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.87670017 |
| 127 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.87670017 |
| 128 | regulation of growth of symbiont in host (GO:0044126) | 2.87670017 |
| 129 | negative regulation of growth of symbiont in host (GO:0044130) | 2.87670017 |
| 130 | leukocyte cell-cell adhesion (GO:0007159) | 2.86817976 |
| 131 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.86329275 |
| 132 | regulation of leukocyte degranulation (GO:0043300) | 2.85949192 |
| 133 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.85832441 |
| 134 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.85605400 |
| 135 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.85508970 |
| 136 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.84130414 |
| 137 | positive regulation of interleukin-10 production (GO:0032733) | 2.83347091 |
| 138 | myeloid leukocyte activation (GO:0002274) | 2.81788038 |
| 139 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.79683999 |
| 140 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.79514906 |
| 141 | positive regulation of interferon-beta production (GO:0032728) | 2.76757557 |
| 142 | regulation of mast cell activation (GO:0033003) | 2.75472474 |
| 143 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.74171562 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.70342096 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.58265590 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.48954164 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.94882159 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.84143299 |
| 6 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.65446461 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.65010755 |
| 8 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.64822619 |
| 9 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.49139193 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.46021955 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.18030681 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.06427032 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.97453487 |
| 14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.70472941 |
| 15 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.65539596 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.63497175 |
| 17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.55998841 |
| 18 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.49855641 |
| 19 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.35320739 |
| 20 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.19473046 |
| 21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.08522417 |
| 22 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.04211391 |
| 23 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.99383950 |
| 24 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.91423969 |
| 25 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.83089604 |
| 26 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.82914547 |
| 27 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.71605563 |
| 28 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.71567503 |
| 29 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.60968969 |
| 30 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.60581337 |
| 31 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.60254092 |
| 32 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.58240284 |
| 33 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.53855746 |
| 34 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.52280510 |
| 35 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.52210031 |
| 36 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.48129256 |
| 37 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.46814032 |
| 38 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.45557061 |
| 39 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.44821887 |
| 40 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.43150485 |
| 41 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.39926974 |
| 42 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.37373611 |
| 43 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.37235313 |
| 44 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.36149996 |
| 45 | SPI1_23127762_ChIP-Seq_K562_Human | 1.36133691 |
| 46 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.35714727 |
| 47 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.35714727 |
| 48 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.35030647 |
| 49 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34735807 |
| 50 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.34640668 |
| 51 | MYB_26560356_Chip-Seq_TH2_Human | 1.34456794 |
| 52 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.33802062 |
| 53 | MAF_26560356_Chip-Seq_TH2_Human | 1.32458301 |
| 54 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.32438136 |
| 55 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.32410233 |
| 56 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.32176162 |
| 57 | MAF_26560356_Chip-Seq_TH1_Human | 1.31381255 |
| 58 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.31233629 |
| 59 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.30114434 |
| 60 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.27191803 |
| 61 | MYC_22102868_ChIP-Seq_BL_Human | 1.24658820 |
| 62 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24088004 |
| 63 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.23640690 |
| 64 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.21302409 |
| 65 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.17321435 |
| 66 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16580134 |
| 67 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.15176475 |
| 68 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13003019 |
| 69 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.11282780 |
| 70 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.11064012 |
| 71 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.10500530 |
| 72 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08334862 |
| 73 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.06570874 |
| 74 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.05326427 |
| 75 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03698209 |
| 76 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02932628 |
| 77 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.02846879 |
| 78 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.02565702 |
| 79 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.02500032 |
| 80 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.02278949 |
| 81 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01496749 |
| 82 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.00553799 |
| 83 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.00553799 |
| 84 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00407528 |
| 85 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00291918 |
| 86 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.00121745 |
| 87 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.99440790 |
| 88 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99220268 |
| 89 | RXR_22108803_ChIP-Seq_LS180_Human | 0.97979715 |
| 90 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97574625 |
| 91 | CJUN_26792858_Chip-Seq_BT549_Human | 0.97556834 |
| 92 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.97332145 |
| 93 | MYB_26560356_Chip-Seq_TH1_Human | 0.97294291 |
| 94 | GATA2_19941826_ChIP-Seq_K562_Human | 0.96963923 |
| 95 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96813442 |
| 96 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96014099 |
| 97 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.95994653 |
| 98 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95311872 |
| 99 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.95250683 |
| 100 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.95177299 |
| 101 | GATA1_22025678_ChIP-Seq_K562_Human | 0.94849497 |
| 102 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.94024646 |
| 103 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.93934027 |
| 104 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.93520535 |
| 105 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.93225887 |
| 106 | GATA3_26560356_Chip-Seq_TH2_Human | 0.93142542 |
| 107 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.92724508 |
| 108 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92375337 |
| 109 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.91403272 |
| 110 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.90466760 |
| 111 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.89434922 |
| 112 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.89434922 |
| 113 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.89434922 |
| 114 | UTX_26944678_Chip-Seq_JUKART_Human | 0.87550991 |
| 115 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.87501402 |
| 116 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.87050363 |
| 117 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.86636488 |
| 118 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.86492257 |
| 119 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.86119046 |
| 120 | GATA1_19941826_ChIP-Seq_K562_Human | 0.84421597 |
| 121 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.81385208 |
| 122 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.81209801 |
| 123 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.79804833 |
| 124 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.79543349 |
| 125 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.79164672 |
| 126 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.78539922 |
| 127 | KDM2B_26808549_Chip-Seq_K562_Human | 0.77574222 |
| 128 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.75404153 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009785_altered_susceptibility_to | 4.09867397 |
| 2 | MP0003303_peritoneal_inflammation | 3.96894708 |
| 3 | MP0003436_decreased_susceptibility_to | 3.88614203 |
| 4 | MP0003724_increased_susceptibility_to | 3.71929945 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 3.11533304 |
| 6 | MP0001835_abnormal_antigen_presentation | 3.04984891 |
| 7 | MP0002419_abnormal_innate_immunity | 3.04812478 |
| 8 | MP0004947_skin_inflammation | 3.00369563 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.98092164 |
| 10 | MP0005025_abnormal_response_to | 2.80697922 |
| 11 | MP0004510_myositis | 2.57628437 |
| 12 | MP0002254_reproductive_system_inflammat | 2.54876226 |
| 13 | MP0005387_immune_system_phenotype | 2.41448154 |
| 14 | MP0001790_abnormal_immune_system | 2.41448154 |
| 15 | MP0001533_abnormal_skeleton_physiology | 2.28206504 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.26373343 |
| 17 | MP0009764_decreased_sensitivity_to | 2.20356128 |
| 18 | MP0002723_abnormal_immune_serum | 2.19024384 |
| 19 | MP0006082_CNS_inflammation | 2.18832358 |
| 20 | MP0001800_abnormal_humoral_immune | 2.11734444 |
| 21 | MP0000343_altered_response_to | 2.10066844 |
| 22 | MP0009278_abnormal_bone_marrow | 2.09700302 |
| 23 | MP0003453_abnormal_keratinocyte_physiol | 2.08611066 |
| 24 | MP0000685_abnormal_immune_system | 2.06659877 |
| 25 | MP0003075_altered_response_to | 1.95377133 |
| 26 | MP0003448_altered_tumor_morphology | 1.94198609 |
| 27 | MP0002405_respiratory_system_inflammati | 1.87216983 |
| 28 | MP0001819_abnormal_immune_cell | 1.85106310 |
| 29 | MP0001845_abnormal_inflammatory_respons | 1.85091738 |
| 30 | MP0005671_abnormal_response_to | 1.84160325 |
| 31 | MP0002420_abnormal_adaptive_immunity | 1.84100308 |
| 32 | MP0005464_abnormal_platelet_physiology | 1.83603154 |
| 33 | MP0003300_gastrointestinal_ulcer | 1.81977418 |
| 34 | MP0002006_tumorigenesis | 1.79811164 |
| 35 | MP0005076_abnormal_cell_differentiation | 1.75877668 |
| 36 | MP0002796_impaired_skin_barrier | 1.70578279 |
| 37 | MP0001853_heart_inflammation | 1.69953337 |
| 38 | MP0005167_abnormal_blood-brain_barrier | 1.69905967 |
| 39 | MP0009840_abnormal_foam_cell | 1.69009861 |
| 40 | MP0003828_pulmonary_edema | 1.62788007 |
| 41 | MP0008469_abnormal_protein_level | 1.62249688 |
| 42 | MP0003191_abnormal_cellular_cholesterol | 1.59476416 |
| 43 | MP0002132_abnormal_respiratory_system | 1.57645597 |
| 44 | MP0008260_abnormal_autophagy | 1.56492051 |
| 45 | MP0010352_gastrointestinal_tract_polyps | 1.52035604 |
| 46 | MP0010155_abnormal_intestine_physiology | 1.49145727 |
| 47 | MP0000858_altered_metastatic_potential | 1.42732073 |
| 48 | MP0005164_abnormal_response_to | 1.41652722 |
| 49 | MP0001216_abnormal_epidermal_layer | 1.41334206 |
| 50 | MP0001851_eye_inflammation | 1.38260784 |
| 51 | MP0005058_abnormal_lysosome_morphology | 1.37969483 |
| 52 | MP0002998_abnormal_bone_remodeling | 1.36014891 |
| 53 | MP0009333_abnormal_splenocyte_physiolog | 1.35624083 |
| 54 | MP0005166_decreased_susceptibility_to | 1.32354265 |
| 55 | MP0003763_abnormal_thymus_physiology | 1.29426593 |
| 56 | MP0005451_abnormal_body_composition | 1.25807767 |
| 57 | MP0000604_amyloidosis | 1.23411163 |
| 58 | MP0003566_abnormal_cell_adhesion | 1.21004041 |
| 59 | MP0001545_abnormal_hematopoietic_system | 1.19778774 |
| 60 | MP0005397_hematopoietic_system_phenotyp | 1.19778774 |
| 61 | MP0005390_skeleton_phenotype | 1.19691201 |
| 62 | MP0003172_abnormal_lysosome_physiology | 1.19637131 |
| 63 | MP0002877_abnormal_melanocyte_morpholog | 1.18957499 |
| 64 | MP0000716_abnormal_immune_system | 1.16827576 |
| 65 | MP0002060_abnormal_skin_morphology | 1.16501446 |
| 66 | MP0002933_joint_inflammation | 1.10169768 |
| 67 | MP0005023_abnormal_wound_healing | 1.10066653 |
| 68 | MP0004858_abnormal_nervous_system | 1.09225149 |
| 69 | MP0002277_abnormal_respiratory_mucosa | 1.08180549 |
| 70 | MP0003186_abnormal_redox_activity | 1.08035367 |
| 71 | MP0004381_abnormal_hair_follicle | 1.06767175 |
| 72 | MP0003705_abnormal_hypodermis_morpholog | 1.06569957 |
| 73 | MP0003183_abnormal_peptide_metabolism | 1.05513964 |
| 74 | MP0005275_abnormal_skin_tensile | 1.02485352 |
| 75 | MP0002398_abnormal_bone_marrow | 1.02414490 |
| 76 | MP0003866_abnormal_defecation | 1.01183610 |
| 77 | MP0001501_abnormal_sleep_pattern | 1.01169870 |
| 78 | MP0010234_abnormal_vibrissa_follicle | 0.99630467 |
| 79 | MP0004782_abnormal_surfactant_physiolog | 0.99619851 |
| 80 | MP0003045_fibrosis | 0.96333152 |
| 81 | MP0003656_abnormal_erythrocyte_physiolo | 0.96113415 |
| 82 | MP0002098_abnormal_vibrissa_morphology | 0.95876947 |
| 83 | MP0009765_abnormal_xenobiotic_induced | 0.94934574 |
| 84 | MP0005310_abnormal_salivary_gland | 0.92558888 |
| 85 | MP0001191_abnormal_skin_condition | 0.92201450 |
| 86 | MP0009763_increased_sensitivity_to | 0.89614635 |
| 87 | MP0001663_abnormal_digestive_system | 0.89269118 |
| 88 | MP0003806_abnormal_nucleotide_metabolis | 0.88723340 |
| 89 | MP0003195_calcinosis | 0.88604754 |
| 90 | MP0000383_abnormal_hair_follicle | 0.87162326 |
| 91 | MP0002429_abnormal_blood_cell | 0.86326421 |
| 92 | MP0004883_abnormal_blood_vessel | 0.84460517 |
| 93 | MP0009931_abnormal_skin_appearance | 0.84368407 |
| 94 | MP0002722_abnormal_immune_system | 0.81837072 |
| 95 | MP0000689_abnormal_spleen_morphology | 0.81441361 |
| 96 | MP0001243_abnormal_dermal_layer | 0.79676848 |
| 97 | MP0000703_abnormal_thymus_morphology | 0.79079352 |
| 98 | MP0003690_abnormal_glial_cell | 0.76715433 |
| 99 | MP0001873_stomach_inflammation | 0.76349092 |
| 100 | MP0008004_abnormal_stomach_pH | 0.75026087 |
| 101 | MP0005501_abnormal_skin_physiology | 0.74795327 |
| 102 | MP0003941_abnormal_skin_development | 0.73945433 |
| 103 | MP0000249_abnormal_blood_vessel | 0.72832347 |
| 104 | MP0010678_abnormal_skin_adnexa | 0.71988215 |
| 105 | MP0000465_gastrointestinal_hemorrhage | 0.71171389 |
| 106 | MP0003795_abnormal_bone_structure | 0.70675243 |
| 107 | MP0002332_abnormal_exercise_endurance | 0.70113685 |
| 108 | MP0002138_abnormal_hepatobiliary_system | 0.68484143 |
| 109 | MP0010771_integument_phenotype | 0.68476706 |
| 110 | MP0003221_abnormal_cardiomyocyte_apopto | 0.67006458 |
| 111 | MP0004808_abnormal_hematopoietic_stem | 0.66817003 |
| 112 | MP0005666_abnormal_adipose_tissue | 0.66099435 |
| 113 | MP0008874_decreased_physiological_sensi | 0.65191313 |
| 114 | MP0002166_altered_tumor_susceptibility | 0.64159924 |
| 115 | MP0005535_abnormal_body_temperature | 0.64005123 |
| 116 | MP0000367_abnormal_coat/_hair | 0.63896519 |
| 117 | MP0005377_hearing/vestibular/ear_phenot | 0.58405115 |
| 118 | MP0003878_abnormal_ear_physiology | 0.58405115 |
| 119 | MP0003091_abnormal_cell_migration | 0.58050025 |
| 120 | MP0006054_spinal_hemorrhage | 0.53689860 |
| 121 | MP0005319_abnormal_enzyme/_coenzyme | 0.52515921 |
| 122 | MP0002396_abnormal_hematopoietic_system | 0.51818371 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.98305909 |
| 2 | Recurrent abscess formation (HP:0002722) | 6.62413404 |
| 3 | Stomatitis (HP:0010280) | 6.04060483 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 5.86484554 |
| 5 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.61841532 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.36892105 |
| 7 | Mediastinal lymphadenopathy (HP:0100721) | 5.15128401 |
| 8 | Orchitis (HP:0100796) | 5.02179409 |
| 9 | Abnormality of macrophages (HP:0004311) | 4.78038008 |
| 10 | Myositis (HP:0100614) | 4.68483898 |
| 11 | Optic neuritis (HP:0100653) | 4.66215070 |
| 12 | Retrobulbar optic neuritis (HP:0100654) | 4.66215070 |
| 13 | Parakeratosis (HP:0001036) | 4.40089331 |
| 14 | Interstitial pulmonary disease (HP:0006530) | 4.24882441 |
| 15 | Systemic lupus erythematosus (HP:0002725) | 3.86348884 |
| 16 | Gingivitis (HP:0000230) | 3.81578382 |
| 17 | Autoimmune thrombocytopenia (HP:0001973) | 3.71064161 |
| 18 | Increased cerebral lipofuscin (HP:0011813) | 3.61986459 |
| 19 | Chronic obstructive pulmonary disease (HP:0006510) | 3.56793980 |
| 20 | Obstructive lung disease (HP:0006536) | 3.56793980 |
| 21 | Thick nail (HP:0001805) | 3.53147568 |
| 22 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.53138916 |
| 23 | Encephalitis (HP:0002383) | 3.42879030 |
| 24 | Urticaria (HP:0001025) | 3.38610323 |
| 25 | Vasculitis (HP:0002633) | 3.37507457 |
| 26 | Recurrent skin infections (HP:0001581) | 3.33723456 |
| 27 | Pustule (HP:0200039) | 3.31486468 |
| 28 | Tetraparesis (HP:0002273) | 3.19028886 |
| 29 | Amyloidosis (HP:0011034) | 3.11627685 |
| 30 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.09292957 |
| 31 | Increased IgE level (HP:0003212) | 3.06860677 |
| 32 | Spontaneous hematomas (HP:0007420) | 3.04831961 |
| 33 | Pulmonary infiltrates (HP:0002113) | 3.03808197 |
| 34 | Recurrent fungal infections (HP:0002841) | 3.03297137 |
| 35 | Vacuolated lymphocytes (HP:0001922) | 3.01392141 |
| 36 | Palmoplantar hyperkeratosis (HP:0000972) | 3.01320552 |
| 37 | Plantar hyperkeratosis (HP:0007556) | 2.98403793 |
| 38 | Periodontitis (HP:0000704) | 2.98267154 |
| 39 | Increased IgM level (HP:0003496) | 2.88194673 |
| 40 | Keratoconjunctivitis sicca (HP:0001097) | 2.86487413 |
| 41 | Myocardial infarction (HP:0001658) | 2.84679859 |
| 42 | Palmar hyperkeratosis (HP:0010765) | 2.83292265 |
| 43 | Chest pain (HP:0100749) | 2.82022172 |
| 44 | Cellulitis (HP:0100658) | 2.80705424 |
| 45 | Pulmonary embolism (HP:0002204) | 2.73333679 |
| 46 | Abnormality of the pleura (HP:0002103) | 2.69151175 |
| 47 | Peritonitis (HP:0002586) | 2.67825839 |
| 48 | Leukocytosis (HP:0001974) | 2.60881990 |
| 49 | Keratoconjunctivitis (HP:0001096) | 2.60326399 |
| 50 | Glomerulonephritis (HP:0000099) | 2.57699068 |
| 51 | Hypergammaglobulinemia (HP:0010702) | 2.56496017 |
| 52 | Gangrene (HP:0100758) | 2.56023355 |
| 53 | Gastrointestinal infarctions (HP:0005244) | 2.53846445 |
| 54 | T lymphocytopenia (HP:0005403) | 2.52864897 |
| 55 | Abnormality of the peritoneum (HP:0002585) | 2.51873306 |
| 56 | Loss of speech (HP:0002371) | 2.49754279 |
| 57 | Abnormality of T cell number (HP:0011839) | 2.49403337 |
| 58 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.46740714 |
| 59 | Nausea (HP:0002018) | 2.46206928 |
| 60 | Osteolytic defects of the hand bones (HP:0009699) | 2.45131480 |
| 61 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.45131480 |
| 62 | Vertebral compression fractures (HP:0002953) | 2.42244335 |
| 63 | Arterial thrombosis (HP:0004420) | 2.41757818 |
| 64 | Prolonged bleeding time (HP:0003010) | 2.41218529 |
| 65 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.36428891 |
| 66 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.35662762 |
| 67 | Premature loss of primary teeth (HP:0006323) | 2.33780561 |
| 68 | Glomerulopathy (HP:0100820) | 2.32796912 |
| 69 | Keratitis (HP:0000491) | 2.32036971 |
| 70 | Anhidrosis (HP:0000970) | 2.31860089 |
| 71 | Inflammation of the large intestine (HP:0002037) | 2.31244996 |
| 72 | Anorexia (HP:0002039) | 2.30520204 |
| 73 | Abnormality of the endocardium (HP:0004306) | 2.30125822 |
| 74 | Vertigo (HP:0002321) | 2.29770698 |
| 75 | Hypochromic microcytic anemia (HP:0004840) | 2.28498536 |
| 76 | Dysostosis multiplex (HP:0000943) | 2.26930921 |
| 77 | Hypochromic anemia (HP:0001931) | 2.26495790 |
| 78 | Nasal polyposis (HP:0100582) | 2.25185525 |
| 79 | Chronic otitis media (HP:0000389) | 2.23537031 |
| 80 | Gingival bleeding (HP:0000225) | 2.23520395 |
| 81 | Acne (HP:0001061) | 2.22736690 |
| 82 | Meningitis (HP:0001287) | 2.21470348 |
| 83 | Hematochezia (HP:0002573) | 2.18223154 |
| 84 | Polyneuropathy (HP:0001271) | 2.18132484 |
| 85 | Gastrointestinal inflammation (HP:0004386) | 2.17825149 |
| 86 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.17576599 |
| 87 | Prostate neoplasm (HP:0100787) | 2.17465656 |
| 88 | Osteomyelitis (HP:0002754) | 2.16280195 |
| 89 | Skin ulcer (HP:0200042) | 2.15779963 |
| 90 | Axonal loss (HP:0003447) | 2.13856550 |
| 91 | Increased serum ferritin (HP:0003281) | 2.12733409 |
| 92 | Granulocytopenia (HP:0001913) | 2.12249917 |
| 93 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.11519806 |
| 94 | Abnormality of glycolipid metabolism (HP:0010969) | 2.11519806 |
| 95 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.11519806 |
| 96 | Hemoptysis (HP:0002105) | 2.11422296 |
| 97 | Recurrent viral infections (HP:0004429) | 2.11327011 |
| 98 | Epistaxis (HP:0000421) | 2.10793688 |
| 99 | Disinhibition (HP:0000734) | 2.10448018 |
| 100 | Recurrent pneumonia (HP:0006532) | 2.09899013 |
| 101 | Esophageal neoplasm (HP:0100751) | 2.08534600 |
| 102 | Neoplasm of head and neck (HP:0012288) | 2.08534600 |
| 103 | Abnormality of the nasal mucosa (HP:0000433) | 2.08451024 |
| 104 | Autoimmune hemolytic anemia (HP:0001890) | 2.02288976 |
| 105 | Episodic fever (HP:0001954) | 2.00812680 |
| 106 | Nephritis (HP:0000123) | 2.00169411 |
| 107 | Basal ganglia calcification (HP:0002135) | 1.99996489 |
| 108 | Purpura (HP:0000979) | 1.99741937 |
| 109 | Colitis (HP:0002583) | 1.98770802 |
| 110 | Bone pain (HP:0002653) | 1.98543715 |
| 111 | Hydroxyprolinuria (HP:0003080) | 1.98105174 |
| 112 | Abnormality of proline metabolism (HP:0010907) | 1.98105174 |
| 113 | Abnormality of T cells (HP:0002843) | 1.96503304 |
| 114 | Eosinophilia (HP:0001880) | 1.95094717 |
| 115 | Abnormality of the pericardium (HP:0001697) | 1.94906651 |
| 116 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.94905250 |
| 117 | Arthralgia (HP:0002829) | 1.91975019 |
| 118 | Mucopolysacchariduria (HP:0008155) | 1.90958693 |
| 119 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.90958693 |
| 120 | Erythema (HP:0010783) | 1.90070886 |
| 121 | Malnutrition (HP:0004395) | 1.89724228 |
| 122 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.88305736 |
| 123 | Recurrent cutaneous fungal infections (HP:0011370) | 1.88305736 |
| 124 | Petechiae (HP:0000967) | 1.87834290 |
| 125 | Abnormality of complement system (HP:0005339) | 1.87488099 |
| 126 | Abnormality of nail color (HP:0100643) | 1.86710057 |
| 127 | Abnormality of iron homeostasis (HP:0011031) | 1.85405247 |
| 128 | Sepsis (HP:0100806) | 1.84448719 |
| 129 | Recurrent bronchitis (HP:0002837) | 1.82570149 |
| 130 | Slow saccadic eye movements (HP:0000514) | 1.80789036 |
| 131 | Joint swelling (HP:0001386) | 1.80709936 |
| 132 | Joint hemorrhage (HP:0005261) | 1.80491567 |
| 133 | Cheilitis (HP:0100825) | 1.80073230 |
| 134 | Hepatosplenomegaly (HP:0001433) | 1.79043897 |
| 135 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.74351764 |
| 136 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.74351764 |
| 137 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.74351764 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 5.38430859 |
| 2 | TBK1 | 4.10686018 |
| 3 | IRAK3 | 3.91417831 |
| 4 | RIPK4 | 3.34537027 |
| 5 | BLK | 3.27697720 |
| 6 | IRAK4 | 2.88609961 |
| 7 | EPHB1 | 2.86843887 |
| 8 | IKBKE | 2.86177650 |
| 9 | ERN1 | 2.71409992 |
| 10 | IKBKB | 2.63533419 |
| 11 | MAP4K1 | 2.54095127 |
| 12 | TYK2 | 2.46974092 |
| 13 | MST4 | 2.40718454 |
| 14 | MST1R | 2.03485026 |
| 15 | CHUK | 2.01849752 |
| 16 | MAP3K3 | 1.94560903 |
| 17 | PRPF4B | 1.86330928 |
| 18 | TXK | 1.85874588 |
| 19 | JAK3 | 1.73369089 |
| 20 | FGR | 1.66566312 |
| 21 | STK10 | 1.65668036 |
| 22 | IRAK2 | 1.62804412 |
| 23 | TNK2 | 1.62061018 |
| 24 | CSK | 1.58435209 |
| 25 | PBK | 1.42108844 |
| 26 | PIM2 | 1.40845398 |
| 27 | EPHA3 | 1.39918824 |
| 28 | ZAP70 | 1.39496019 |
| 29 | JAK1 | 1.35081384 |
| 30 | KIT | 1.31738801 |
| 31 | BMX | 1.28560195 |
| 32 | RIPK1 | 1.25315170 |
| 33 | RPS6KA4 | 1.09093386 |
| 34 | TAOK3 | 1.07801052 |
| 35 | JAK2 | 1.07717898 |
| 36 | BMPR2 | 1.07193006 |
| 37 | CDC42BPA | 1.06679019 |
| 38 | EIF2AK2 | 1.06030766 |
| 39 | ABL2 | 1.05494792 |
| 40 | FGFR3 | 1.04761124 |
| 41 | HCK | 1.03948889 |
| 42 | ERBB4 | 1.02307170 |
| 43 | MAP3K11 | 1.01739783 |
| 44 | MAP3K1 | 0.99954745 |
| 45 | SYK | 0.98335496 |
| 46 | MARK3 | 0.96619772 |
| 47 | TGFBR2 | 0.93820846 |
| 48 | PRKG2 | 0.93467953 |
| 49 | LRRK2 | 0.88306177 |
| 50 | FGFR4 | 0.85285108 |
| 51 | MARK2 | 0.84265996 |
| 52 | BTK | 0.82769633 |
| 53 | MAP3K6 | 0.81996855 |
| 54 | PIM1 | 0.81353582 |
| 55 | FES | 0.81016793 |
| 56 | SIK3 | 0.79407325 |
| 57 | MAP3K5 | 0.77320398 |
| 58 | PTK6 | 0.76115486 |
| 59 | LYN | 0.75314995 |
| 60 | MAP2K3 | 0.74634936 |
| 61 | CSF1R | 0.73434392 |
| 62 | LCK | 0.71156623 |
| 63 | PDK1 | 0.70831766 |
| 64 | MAPKAPK2 | 0.70275022 |
| 65 | PIK3CG | 0.69767857 |
| 66 | PDPK1 | 0.69426095 |
| 67 | CLK1 | 0.69283717 |
| 68 | MATK | 0.67853250 |
| 69 | PRKD2 | 0.64594482 |
| 70 | MAP3K13 | 0.63246309 |
| 71 | ALK | 0.63153110 |
| 72 | IRAK1 | 0.63102243 |
| 73 | MAP3K2 | 0.62490383 |
| 74 | GRK7 | 0.59734239 |
| 75 | ERBB3 | 0.59728042 |
| 76 | KSR2 | 0.59071721 |
| 77 | EGFR | 0.57952919 |
| 78 | ABL1 | 0.57736530 |
| 79 | MAPK7 | 0.57390985 |
| 80 | PRKCD | 0.56396333 |
| 81 | MAPK4 | 0.54938490 |
| 82 | TRPM7 | 0.54557980 |
| 83 | MAP2K6 | 0.54518444 |
| 84 | TEC | 0.54363883 |
| 85 | DDR2 | 0.53246446 |
| 86 | TESK2 | 0.51299667 |
| 87 | HIPK2 | 0.50907367 |
| 88 | TTN | 0.49811727 |
| 89 | MAP3K10 | 0.48290249 |
| 90 | RPS6KA1 | 0.48015347 |
| 91 | MET | 0.45625451 |
| 92 | DYRK1B | 0.44323649 |
| 93 | SIK2 | 0.43557862 |
| 94 | GSK3A | 0.43312489 |
| 95 | TAOK1 | 0.43198406 |
| 96 | PTK2B | 0.41714938 |
| 97 | MOS | 0.40143524 |
| 98 | NEK9 | 0.40031994 |
| 99 | SIK1 | 0.38415752 |
| 100 | MAPK12 | 0.38379606 |
| 101 | MAP2K4 | 0.38074747 |
| 102 | DAPK2 | 0.37641881 |
| 103 | MAP3K12 | 0.37518865 |
| 104 | TAOK2 | 0.37479808 |
| 105 | DYRK3 | 0.37282486 |
| 106 | TESK1 | 0.36306667 |
| 107 | MAP3K7 | 0.35445959 |
| 108 | STK38 | 0.35332437 |
| 109 | KSR1 | 0.35059653 |
| 110 | RPS6KL1 | 0.34775384 |
| 111 | RPS6KC1 | 0.34775384 |
| 112 | GRK6 | 0.34653987 |
| 113 | SGK3 | 0.34423136 |
| 114 | STK24 | 0.32414409 |
| 115 | PRKAA2 | 0.32389981 |
| 116 | RAF1 | 0.32082218 |
| 117 | CDK19 | 0.31915197 |
| 118 | PAK4 | 0.31832113 |
| 119 | SMG1 | 0.31196303 |
| 120 | ITK | 0.31177590 |
| 121 | STK11 | 0.30507541 |
| 122 | RET | 0.28999763 |
| 123 | FYN | 0.28270489 |
| 124 | RPS6KA6 | 0.24352627 |
| 125 | CDK6 | 0.24178085 |
| 126 | MAPK3 | 0.24050499 |
| 127 | TRIB3 | 0.23519584 |
| 128 | BCR | 0.22067937 |
| 129 | PDGFRB | 0.20641947 |
| 130 | YES1 | 0.20232850 |
| 131 | PRKCQ | 0.19361419 |
| 132 | NLK | 0.17308504 |
| 133 | MAP2K2 | 0.17239668 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.99972235 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.58918001 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.20277567 |
| 4 | Legionellosis_Homo sapiens_hsa05134 | 3.05774958 |
| 5 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 3.02709815 |
| 6 | Malaria_Homo sapiens_hsa05144 | 2.84513915 |
| 7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.80137133 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.69036068 |
| 9 | Pertussis_Homo sapiens_hsa05133 | 2.55547952 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.51002960 |
| 11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.41038445 |
| 12 | Asthma_Homo sapiens_hsa05310 | 2.41037287 |
| 13 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.34331992 |
| 14 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.29656974 |
| 15 | Allograft rejection_Homo sapiens_hsa05330 | 2.24518556 |
| 16 | Tuberculosis_Homo sapiens_hsa05152 | 2.24189808 |
| 17 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.19701551 |
| 18 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.16511480 |
| 19 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.91308894 |
| 20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.83671965 |
| 21 | Salmonella infection_Homo sapiens_hsa05132 | 1.83018976 |
| 22 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.66538078 |
| 23 | Measles_Homo sapiens_hsa05162 | 1.64760763 |
| 24 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.64364712 |
| 25 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.63968538 |
| 26 | Influenza A_Homo sapiens_hsa05164 | 1.57061782 |
| 27 | Phagosome_Homo sapiens_hsa04145 | 1.40414461 |
| 28 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.35530695 |
| 29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.32268127 |
| 30 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.29814385 |
| 31 | Lysosome_Homo sapiens_hsa04142 | 1.26040015 |
| 32 | Amoebiasis_Homo sapiens_hsa05146 | 1.22671292 |
| 33 | Apoptosis_Homo sapiens_hsa04210 | 1.16320650 |
| 34 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.15278219 |
| 35 | Shigellosis_Homo sapiens_hsa05131 | 1.12086307 |
| 36 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.09182472 |
| 37 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.07557157 |
| 38 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.06744552 |
| 39 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.02010348 |
| 40 | Prion diseases_Homo sapiens_hsa05020 | 1.00659533 |
| 41 | Hepatitis C_Homo sapiens_hsa05160 | 0.98682740 |
| 42 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.94659851 |
| 43 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.92634955 |
| 44 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.92194039 |
| 45 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.91353558 |
| 46 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.91051604 |
| 47 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.89345057 |
| 48 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.87610095 |
| 49 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.87422208 |
| 50 | Other glycan degradation_Homo sapiens_hsa00511 | 0.87033906 |
| 51 | Hepatitis B_Homo sapiens_hsa05161 | 0.86704692 |
| 52 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.79319590 |
| 53 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.78195351 |
| 54 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.76020878 |
| 55 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.75322334 |
| 56 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.71090308 |
| 57 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.68898318 |
| 58 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.68493780 |
| 59 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.66196740 |
| 60 | Mineral absorption_Homo sapiens_hsa04978 | 0.65373201 |
| 61 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.61758237 |
| 62 | Bladder cancer_Homo sapiens_hsa05219 | 0.59382163 |
| 63 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.57904820 |
| 64 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56191157 |
| 65 | Viral myocarditis_Homo sapiens_hsa05416 | 0.53594597 |
| 66 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.53382616 |
| 67 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.50098081 |
| 68 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49067091 |
| 69 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.48718636 |
| 70 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.48485599 |
| 71 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.47772047 |
| 72 | Insulin resistance_Homo sapiens_hsa04931 | 0.47022733 |
| 73 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.45393041 |
| 74 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.45066818 |
| 75 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.44253531 |
| 76 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.44089316 |
| 77 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.44001283 |
| 78 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.39804579 |
| 79 | Platelet activation_Homo sapiens_hsa04611 | 0.38699652 |
| 80 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.37251507 |
| 81 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.36697408 |
| 82 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.36616367 |
| 83 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.36424577 |
| 84 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.35972746 |
| 85 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.35578971 |
| 86 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.34725478 |
| 87 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.33390183 |
| 88 | Endometrial cancer_Homo sapiens_hsa05213 | 0.32370174 |
| 89 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.32045704 |
| 90 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.30971367 |
| 91 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.30422959 |
| 92 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.30297676 |
| 93 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.29568063 |
| 94 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.28550087 |
| 95 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.28359170 |
| 96 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.28172780 |
| 97 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.28159109 |
| 98 | Prostate cancer_Homo sapiens_hsa05215 | 0.24070019 |
| 99 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.23265386 |
| 100 | HTLV-I infection_Homo sapiens_hsa05166 | 0.21451771 |
| 101 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.21258973 |
| 102 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.20763102 |
| 103 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.18647521 |
| 104 | Histidine metabolism_Homo sapiens_hsa00340 | 0.17529723 |
| 105 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.16385632 |
| 106 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.13295266 |
| 107 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.13119189 |
| 108 | Endocytosis_Homo sapiens_hsa04144 | 0.12627895 |
| 109 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.12372246 |
| 110 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.11578045 |
| 111 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.11037488 |
| 112 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.10904447 |
| 113 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.10373026 |
| 114 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.10080006 |

